Literature DB >> 2873049

Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence.

D Mirelman, R Bracha, A Chayen, A Aust-Kettis, L S Diamond.   

Abstract

In xenic culture, isolates of Entamoeba histolytica from asymptomatic carriers are characterized, with rare exception, by possession of a nonpathogenic zymodeme. During the process of axenizing such an isolate, strain CDC:0784:4, a change in the pattern of the isoenzymes from nonpathogenic zymodeme I to pathogenic zymodeme II was observed 40 days after the amebae had been transferred from a medium for xenic cultivation to one used for axenic cultivation, but before axenization of the amebae had actually occurred. Axenization was accomplished by feeding the amebae lethally irradiated bacteria while suppressing and finally eradicating with antibiotics the bacterial flora accompanying the amebae in the original xenic culture. The change in zymodeme was accompanied by a change in virulence as evidenced by the ability of the amebae to produce hepatic abscesses in hamsters and to destroy monolayers of tissue culture cells. Two explanations are offered for the observed changes in zymodeme and virulence: a zymodeme is not a stable inherent property of the ameba. Alternatively, the original isolate consisted of two zymodeme populations and the conditions of growth selected for one or the other of the populations. In either case, our results suggest that the finding of a particular zymodeme in a culture of E. histolytica isolated from an asymptomatic carrier of the parasite cannot be used to predict a clinical condition or serve as a basis for the recommendation of therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873049     DOI: 10.1016/0014-4894(86)90017-2

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  22 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Autonomous replication sequences in an extrachromosomal element of a pathogenic Entamoeba histolytica.

Authors:  J Grodberg; N Salazar; R Oren; D Mirelman
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

Review 3.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

4.  Repetitive DNA elements characteristic of pathogenic Entamoeba histolytica strains can also be detected after polymerase chain reaction in a cloned nonpathogenic strain.

Authors:  D Mirelman; R Bracha; S Rozenblatt; L I Garfinkel
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 5.  Regulation of gene expression in protozoa parasites.

Authors:  Consuelo Gomez; M Esther Ramirez; Mercedes Calixto-Galvez; Olivia Medel; Mario A Rodríguez
Journal:  J Biomed Biotechnol       Date:  2010-03-02

6.  Control of ferredoxin and Gal/GalNAc lectin gene expression in Entamoeba histolytica by a cis-acting DNA sequence.

Authors:  C A Gilchrist; B J Mann; W A Petri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 7.  Ameba-bacterium relationship in amebiasis.

Authors:  D Mirelman
Journal:  Microbiol Rev       Date:  1987-06

8.  Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction.

Authors:  H Tachibana; S Ihara; S Kobayashi; Y Kaneda; T Takeuchi; Y Watanabe
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Differentiation of clinical isolates of Entamoeba histolytica by using specific DNA probes.

Authors:  R Bracha; L S Diamond; J P Ackers; G D Burchard; D Mirelman
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

10.  Isolation of a strain-specific Entamoeba histolytica cDNA clone.

Authors:  D J Burch; E Li; S Reed; T F Jackson; S L Stanley
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.